The frequency of cardiovascular death , myocardial infarction , or stroke in current smokers was significantly lower with prasugrel ( 11.7 % ) vs. clopidogrel ( 18.6 % ) , but there was no difference in non-smokers ( 13.8 % vs. 13.7 % ) , with significant interaction between treatment and baseline smoking status ( P = .0002 ) .